Shaoxing Zhu

机构：Fujian Medical University, Union Hospital

发表论文 60 篇 · 总被引 843 次 · h-index 16

代表论文

• Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial (2022 · The Lancet Oncology · 被引 69)
• A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma (2022 · Frontiers in Genetics · 被引 58)
• Efficacy and intrarenal pressure analysis of flexible and navigable suction ureteral access sheaths with flexible ureteroscopy in modified surgical positions for 2–6 cm upper urinary tract stones: a multicenter retrospective study (2024 · Frontiers in Medicine · 被引 29)
• Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial (2022 · BMC Medicine · 被引 23)
• CACA guidelines for holistic integrative management of prostate cancer (2024 · Holistic Integrative Oncology · 被引 22)
• PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration (2022 · Frontiers in Oncology · 被引 19)